XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
Public ClinicalTrials.gov record NCT00090025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to determine if XL119 is more effective than the combination of 5-fluorouracil (5FU) and leucovorin (LV) in prolonging the survival of subjects with advanced biliary tumors.
Study identification
- NCT ID
- NCT00090025
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2004 (Type not available)
- Primary completion
- Nov 2006 (Actual)
- Completion
- Nov 2006 (Actual)
- Last update posted
- Jan 14, 2009
2004 – 2006
United States locations
- U.S. sites
- 27
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Long Beach VA Medical Center | Long Beach | California | 90822 | — |
| University of California, Irvine Medical Center | Orange | California | 92868 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Winship Cancer Institute, Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Carle Clinic Association | Urbana | Illinois | 61801 | — |
| Medical Consultants, PC c/o Ball Cancer Center | Muncie | Indiana | 47303 | — |
| Oncology Associates | Cedar Rapids | Iowa | 52403 | — |
| Louisiana Oncology Associates | Lafayette | Louisiana | 70506 | — |
| Tufts - New England Medical Center | Boston | Massachusetts | 02111 | — |
| Josephine Ford Cancer Center at Henry Ford Health System | Detroit | Michigan | 48202 | — |
| West Michigan Cancer Center | Kalamazoo | Michigan | 49007 | — |
| Oncology Care Center PLLC | Saint Joseph | Michigan | 49085 | — |
| Norris Cotton Cancer Center | Lebanon | New Hampshire | 03756 | — |
| Queens Hospital Center | Jamaica | New York | 11432 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Cancer Treatment and Research Center | Bismarck | North Dakota | 58501 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106 | — |
| Charleston Hematology Oncology, PA | Charleston | South Carolina | 29403 | — |
| The Sarah Cannon Cancer Center | Nashville | Tennessee | 37203 | — |
| Western Washington Oncology, Inc. | Lacey | Washington | 98503 | — |
| University of Wisconsin Comprehensive Cancer Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00090025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2009 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00090025 live on ClinicalTrials.gov.